000 | 01857cam a22004094a 4500 | ||
---|---|---|---|
001 | P 1200 | ||
005 | 20140212102803.0 | ||
008 | 050614s2006 njua b 001 0 eng | ||
010 | _a 2005017065 | ||
016 | 7 |
_a101267017 _2DNLM |
|
020 | _a1588295648 (alk. paper) | ||
035 | _a(OCoLC)ocm60651107 | ||
040 |
_aDLC _cDLC _dYDX _dBAKER _dVAM _dCUX _dNLM _dMUQ _dDLC |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRC271.I45 _bI45-2006 |
060 | 0 | 0 | _a2006 B-494 |
060 | 1 | 0 |
_aQZ 266 _bI33 2006 |
082 | 0 | 0 |
_a616.99/4061 _222 |
245 | 0 | 0 |
_aImmunotherapy of cancer / _cedited by Mary L. Disis. |
260 |
_aTotowa, N.J. : _bHumana Press, _cc2006. |
||
300 |
_axii, 516 p. : _bill. ; _c26 cm. |
||
490 | 0 | _aCancer drug discovery and development | |
504 | _aIncludes bibliographical references and index. | ||
505 | _aDiscovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches -- Current strategies for the identification of immunogenic epitopes of tumor antigens -- Current and future role of natural-killer cells in cancer im | ||
650 | 0 |
_aAntineoplastic agents _xDesign. |
|
650 | 0 |
_aCancer _xImmunotherapy. |
|
650 | 1 | 2 |
_aNeoplasms _ximmunology. |
650 | 1 | 2 |
_aNeoplasms _xtherapy. |
650 | 2 | 2 | _aImmunotherapy. |
700 | 1 | _aDisis, Mary L. | |
856 | 4 | 1 |
_3Table of contents _uhttp://www.loc.gov/catdir/toc/ecip0514/2005017065.html |
856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0825/2005017065-d.html |
906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
925 | 0 |
_aacquire _b2 shelf copies _xpolicy default |
|
942 | _cBK | ||
955 |
_djc01 2005-06-14 _ejc41 2005-06-14 _fjc14 2006-07-06 Z-CipVer _gjc14 2006-07-06 to BCCD |
||
999 |
_c6313 _d6313 |